This article was originally published in The Gray Sheet
Executive SummaryBlood glucose monitor launched Aug. 1 is "virtually pain-free," since it uses only 0.3 microliters of blood taken from the arm and obviates the need for larger fingertip blood samples, the company claims. Cleared via 510(k) in January, the device uses "less [blood] than other blood glucose monitoring systems on the market," according to the Alameda, California firm. The FreeStyle meter uses coulometric technology to minimize the needed sample size and retails for $75; test strips used with the meter are priced at $39 for 50 or $69 for 100
You may also be interested in...
Scrip’s on-the-ground team in Asia talks about how the regional and wider pharma industry and policymakers have responded so far to the spreading coronavirus outbreak, with a focus on the expedited development of potential drugs and vaccines.
Oncologic Drugs Advisory Committee votes 6-5 that ramucirumab’s benefit/risk profile is favorable in first-line lung cancer, but 13-2 that pivotal trial data do not support approval of Steba’s vascular-targeted, photodynamic therapy for low-risk prostate cancer.